G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 127 filers reported holding G1 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $113,000 | -26.6% | 14,906 | -1.0% | 0.00% | – |
| Q4 2021 | $154,000 | -91.0% | 15,059 | -88.2% | 0.00% | -100.0% |
| Q3 2021 | $1,715,000 | -43.1% | 127,787 | -7.0% | 0.00% | -50.0% |
| Q2 2021 | $3,014,000 | -27.2% | 137,358 | -20.1% | 0.01% | -25.0% |
| Q1 2021 | $4,138,000 | -0.7% | 172,013 | -25.7% | 0.01% | 0.0% |
| Q4 2020 | $4,166,000 | +44.1% | 231,581 | -7.5% | 0.01% | +33.3% |
| Q3 2020 | $2,892,000 | -35.2% | 250,410 | +36.0% | 0.01% | -40.0% |
| Q2 2020 | $4,464,000 | +94.9% | 184,064 | -11.4% | 0.01% | +66.7% |
| Q1 2020 | $2,290,000 | -23.5% | 207,766 | +83.4% | 0.01% | 0.0% |
| Q4 2019 | $2,994,000 | -31.3% | 113,286 | -40.8% | 0.01% | -40.0% |
| Q3 2019 | $4,361,000 | -54.3% | 191,433 | -38.4% | 0.01% | -50.0% |
| Q2 2019 | $9,534,000 | +18.8% | 310,945 | -35.7% | 0.02% | +11.1% |
| Q1 2019 | $8,027,000 | +72.8% | 483,559 | +99.3% | 0.02% | +63.6% |
| Q4 2018 | $4,646,000 | -74.9% | 242,617 | -31.4% | 0.01% | -71.1% |
| Q3 2018 | $18,493,000 | -5.4% | 353,656 | -21.4% | 0.04% | -9.5% |
| Q2 2018 | $19,550,000 | +9254.1% | 449,834 | +7889.9% | 0.04% | – |
| Q1 2018 | $209,000 | – | 5,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |